| 1 |
Eugene de Juan, Jr. |
Forsight Vision4 |
8 |
| 2 |
Signe Erickson |
Forsight Vision4 |
6 |
| 3 |
Eric Andrew Evans |
Myriad Women'S Health |
5 |
| #4 |
Hugo Peris |
Spiral Therapeutics |
4 |
| #4 |
Charles Behling |
Verily Life Sciences |
4 |
| #6 |
Michael E. Woods |
Unknown |
3 |
| #6 |
Brett G. Crockett |
Dolby Laboratories Licensing |
3 |
| #6 |
Brian M. Fox |
Denali Therapeutics |
3 |
| #9 |
Melissa Fleury |
Theravance Biopharma R&D Ip |
2 |
| #9 |
Vikas Aggarwal |
Google |
2 |
| #9 |
Karim Dabbagh |
Second Genome |
2 |
| #9 |
Megan Dueck |
Combinati Incorporated |
2 |
| #9 |
Andrew Wonhee Han |
Second Genome |
2 |
| #9 |
Laura Serwer |
Omniox |
2 |
| #9 |
Jamie Dananberg |
Unity Biotechnology |
2 |
| #9 |
Gary Alan Lipkowitz |
Goanimate |
2 |
| #9 |
Robert Sobecki |
Verily Life Sciences |
2 |
| #9 |
Alexander Gorer |
Intermolecular |
2 |
| #9 |
Charles Limb |
Spiral Therapeutics |
2 |
| #9 |
Vrad Levering |
Spiral Therapeutics |
2 |
| #9 |
Matthew Clarke |
Forsight Vision6 |
2 |
| #9 |
Todd Zachary DeSantis |
Second Genome |
2 |
| #9 |
Sunil Sudhakaran |
NVIDIA |
2 |
| #24 |
Hector Rodriguez |
Gilead Biologics |
1 |
| #24 |
Alex Bain |
— |
1 |
| #24 |
Jihee Kim |
Samsung |
1 |
| #24 |
Harry Sweigard |
Unity Biotechnology |
1 |
| #24 |
Yuliya Katlinskaya |
— |
1 |
| #24 |
William F. O'Keeffe |
— |
1 |
| #24 |
Andrew W. Goodyear |
Second Genome |
1 |
| #24 |
John Randall Gobbel |
Illumina |
1 |
| #24 |
Isidro Hotzel |
Genentech |
1 |
| #24 |
Ayman Naseri |
— |
1 |
| #24 |
Robert Anderson |
Myokardia |
1 |
| #24 |
Carol M. Culver |
Sigma Computing |
1 |
| #24 |
Sriharsha Mukundappa Sathyavathi |
Amazon |
1 |
| #24 |
Johannes P. Schneeberger |
Ritchey Design |
1 |
| #24 |
Priyanka Chandrasekaran |
Danisco Us |
1 |
| #24 |
Gregory E. Leyh |
Google |
1 |
| #24 |
Pam Tsuruda |
Unity Biotechnology |
1 |
| #24 |
Phillip Duffy |
Genentech |
1 |
| #24 |
Carl Allen Henderson, Jr. |
Impossible Foods |
1 |
| #24 |
Moawia Eldeeb |
— |
1 |
| #24 |
Storrs T. Hoen |
Apple |
1 |
| #24 |
Randi K. GBUR |
Tricida |
1 |
| #24 |
Kathy HÖTZEL |
Genentech |
1 |
| #24 |
Jim Fink |
Aerami Therapeutics |
1 |
| #24 |
Minha Park |
Trellis Bioscience |
1 |
| #24 |
Tarunmeet Gujral |
Second Genome |
1 |
| #24 |
James P. Roane |
Merck |
1 |